Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial
- PMID: 14970093
- PMCID: PMC332712
Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial
Abstract
Background: The optimal duration of antibiotic therapy in older patients with uncomplicated urinary tract infection (UTI) is still a matter of debate. The aim of this randomized controlled double-blind noninferiority trial was to compare the efficacy and safety of 3-day and 7-day courses of oral ciprofloxacin for uncomplicated symptomatic UTI in older women.
Methods: A total of 183 women at least 65 years of age with acute uncomplicated UTI were recruited from ambulatory clinics and hospital acute care units. Patients with pyelonephritis, contraindications to fluoroquinolones, recent use of antibiotics, urinary tract abnormalities and diabetes mellitus were excluded. Women were randomly assigned to receive either ciprofloxacin 250 mg twice daily orally for 3 days followed by placebo for 4 days (the 3-day group, 93 patients) or ciprofloxacin 250 mg twice daily orally for 7 days (the 7-day group, 90 patients). Bacterial eradication, clinical improvement and occurrence of adverse events were determined 2 days after completion of treatment, and occurrence of reinfection or relapse were determined 6 weeks after completion of treatment. Bacterial eradication and relapse were determined by urine culture. Double-blind procedures were maintained throughout data collection.
Results: The proportion of patients with bacterial eradication at 2 days after treatment was 98% (91/93) in the 3-day group and 93% (83/89) in the 7-day group (p = 0.16). The frequency of adverse events, including drowsiness, headache, nausea or vomiting, and loss of appetite, was significantly lower in the 3-day group.
Interpretation: These results suggest that a 3-day course of antibiotic therapy is not inferior to a 7-day course for treatment of uncomplicated symptomatic UTI in older women, and that the shorter course is better tolerated.
Figures
Comment in
-
3 days ciprofloxacin adequate for UTI in older women.J Fam Pract. 2004 Jun;53(6):447-8. J Fam Pract. 2004. PMID: 15189716 No abstract available.
Similar articles
-
Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.Int J Antimicrob Agents. 2004 Jun;23(6):596-605. doi: 10.1016/j.ijantimicag.2003.12.017. Int J Antimicrob Agents. 2004. PMID: 15194131 Clinical Trial.
-
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.J Antimicrob Chemother. 1999 Mar;43 Suppl A:67-75. J Antimicrob Chemother. 1999. PMID: 10225575 Clinical Trial.
-
Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].Arch Intern Med. 1995 Mar 13;155(5):485-94. Arch Intern Med. 1995. PMID: 7864704 Clinical Trial.
-
Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S54-66. doi: 10.1016/j.ijantimicag.2003.12.005. Int J Antimicrob Agents. 2004. PMID: 15037329 Review.
-
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.Dan Med Bull. 2011 Apr;58(4):B4187. Dan Med Bull. 2011. PMID: 21466767 Review.
Cited by
-
Plasmonic Fluorescence Sensors in Diagnosis of Infectious Diseases.Biosensors (Basel). 2024 Mar 2;14(3):130. doi: 10.3390/bios14030130. Biosensors (Basel). 2024. PMID: 38534237 Free PMC article. Review.
-
Evaluation of the Diagnosis and Antibiotic Prescription Pattern in Patients Hospitalized with Urinary Tract Infections: Single-Center Study from a University-Affiliated Hospital.Antibiotics (Basel). 2023 Dec 1;12(12):1689. doi: 10.3390/antibiotics12121689. Antibiotics (Basel). 2023. PMID: 38136723 Free PMC article.
-
Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection.Antimicrob Steward Healthc Epidemiol. 2022 Oct 21;2(1):e171. doi: 10.1017/ash.2022.317. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36483378 Free PMC article.
-
In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole.Microorganisms. 2021 Nov 2;9(11):2279. doi: 10.3390/microorganisms9112279. Microorganisms. 2021. PMID: 34835405 Free PMC article.
-
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections.Clin Microbiol Rev. 2021 Dec 15;34(4):e0000320. doi: 10.1128/CMR.00003-20. Epub 2021 Aug 25. Clin Microbiol Rev. 2021. PMID: 34431702 Free PMC article. Review.
References
-
- Nicolle LE. Urinary tract infection in the elderly. J Antimicrob Chemother 1994;33(Suppl A):99-109. - PubMed
-
- Mulholand SG. Urinary tract infection. Clin Geriatr Med 1990;6(1):43-53. - PubMed
-
- Gray RP, Malone-Lee J. Urinary tract infection in elderly people — time to review management? [review]. Age Ageing 1995;24(4):341-5. - PubMed
-
- Beyer I, Mergam A, Benoit F, Theunissen C, Pepersack T. Management of urinary tract infections in the elderly. Z Gerontol Geriat 2001;34(2):153-7. - PubMed
-
- Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women [Cochrane review]. In: The Cochrane Library; issue 3, 2002. Oxford: Update Software. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical